CD276 and neoplasm: The ex vivo RP-B7-H3 CAR T cells mediated complete tumor rejection in 100% of mice bearing orthotopic PANC-1 cell line-derived solid tumor xenografts, and the mice remained tumor-free for the length of the experiment.